- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有270家主力机构披露2024-12-31报告期持股数据，持仓量总计2.43亿股，占流通A股61.50%
- 波段诊断：
-
技术面诊股
诊断结果：7.7技术面打败了77%的股票
技术面评分前10的股票
近期的平均成本为23.34元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为23.34元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"23.34","date":1752741402,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2025.07.18","stock":"-0.21","trade":null,"ind":"0.37"},{"date":"2025.07.17","stock":"0.30","trade":null,"ind":"1.43"},{"date":"2025.07.16","stock":"-0.09","trade":null,"ind":"-0.22"},{"date":"2025.07.15","stock":"2.45","trade":null,"ind":"0.56"},{"date":"2025.07.14","stock":"0.04","trade":null,"ind":"-0.11"},{"date":"2025.07.11","stock":"0.26","trade":null,"ind":"0.61"},{"date":"2025.07.10","stock":"1.65","trade":null,"ind":"0.47"},{"date":"2025.07.09","stock":"-1.93","trade":null,"ind":"-0.06"},{"date":"2025.07.08","stock":"5.50","trade":null,"ind":"1.46"},{"date":"2025.07.07","stock":"0.14","trade":null,"ind":"-0.70"},{"date":"2025.07.04","stock":"0.75","trade":null,"ind":"-0.25"},{"date":"2025.07.03","stock":"0.85","trade":null,"ind":"1.17"},{"date":"2025.07.02","stock":"-1.48","trade":null,"ind":"-0.61"},{"date":"2025.07.01","stock":"0.33","trade":null,"ind":"0.11"},{"date":"2025.06.30","stock":"2.18","trade":null,"ind":"0.83"},{"date":"2025.06.27","stock":"-0.19","trade":null,"ind":"0.34"},{"date":"2025.06.26","stock":"-1.91","trade":null,"ind":"-0.48"},{"date":"2025.06.25","stock":"0.94","trade":null,"ind":"1.72"},{"date":"2025.06.24","stock":"1.14","trade":null,"ind":"1.68"},{"date":"2025.06.23","stock":"0.81","trade":null,"ind":"0.43"},{"date":"2025.06.20","stock":"0.34","trade":null,"ind":"-0.47"}]
艾德生物,深证成指,医疗器械指数
压力支撑
该股压力位为23.36元，支撑位为22.99元。
[{"text":"\u538b\u529b\u4f4d","value":"23.36","date":1752768000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"22.99","date":1752768000,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.8资金面打败了61%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月18日 20:34
| 机构今日流向(万元) | 226.73 | 机构5日流向(万元) | -1678.71 |
| 机构10日流向(万元) | -4303.49 | 机构20日流向(万元) | -6686.98 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量增加1176.95万股，其中基金净减仓3家，主力净增仓106家，请投资者中长期谨慎为宜。
截止2024-12-31，共270家主力机构（基金263家，社保基金2家，一般法人5家），持仓量总计24287.49万股，占流通A股61.50%
其中，基金持仓与2024-06-30相比：
增仓：43家 ，增持 644.01万股
减仓：46家 ，减持 512.73万股
新出现在主力名单中：170家 ，持有2936.75万股
从主力名单中消失：64家 ，原持有1572.09万股
其中，基金持仓与2024-06-30相比：
增仓：43家 ，增持 644.01万股
减仓：46家 ，减持 512.73万股
新出现在主力名单中：170家 ，持有2936.75万股
从主力名单中消失：64家 ，原持有1572.09万股
消息面诊股
诊断结果：6.6消息面打败了80%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 艾德生物：7月17日获融资买入2662.97万元，
2025-07-18 - 艾德生物：7月16日获融资买入2692.90万元
2025-07-17 - 艾德生物：7月14日获融资买入1678.31万元，
2025-07-15 - 艾德生物：7月11日获融资买入1958.23万元，
2025-07-14 - 艾德生物：7月10日获融资买入2220.04万元，
2025-07-11 - 艾德生物：7月9日获融资买入2075.91万元
2025-07-10 - 艾德生物：7月8日获融资买入4750.36万元，占
2025-07-09 - 华夏中证智选1000成长创新策略ETF重仓股艾德生
2025-07-08 - 艾德生物：7月7日获融资买入1774.57万元，占
2025-07-08 - 概念动态|艾德生物新增“创新药”概念
2025-07-07
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-22 |
| 利好 | 分红转增 | 10派3元(含税) | 2025-04-22 |
| 一般消息 | 高管变动 | 调整职位名称 | 2025-01-08 |
| 一般消息 | 高管变动 | 因工作调整 | 2025-01-07 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-07-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.07.18","price":"0.37","value":null},{"date":"2025.07.17","price":"1.43","value":null},{"date":"2025.07.16","price":"-0.22","value":null},{"date":"2025.07.15","price":"0.56","value":null},{"date":"2025.07.14","price":"-0.11","value":null},{"date":"2025.07.11","price":"0.61","value":null},{"date":"2025.07.10","price":"0.47","value":null},{"date":"2025.07.09","price":"-0.06","value":null},{"date":"2025.07.08","price":"1.46","value":null},{"date":"2025.07.07","price":"-0.70","value":null},{"date":"2025.07.04","price":"-0.25","value":null},{"date":"2025.07.03","price":"1.17","value":null},{"date":"2025.07.02","price":"-0.61","value":null},{"date":"2025.07.01","price":"0.11","value":null},{"date":"2025.06.30","price":"0.83","value":null},{"date":"2025.06.27","price":"0.34","value":null},{"date":"2025.06.26","price":"-0.48","value":null},{"date":"2025.06.25","price":"1.72","value":null},{"date":"2025.06.24","price":"1.68","value":null},{"date":"2025.06.23","price":"0.43","value":null},{"date":"2025.06.20","price":"-0.47","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 热景生物 | 49.47% | 6.42% | 5.3分 |
| 2 | ST凯利 | 36.22% | 0.66% | 5.6分 |
| 3 | 康众医疗 | 35.65% | 23.96% | 6.0分 |
| 4 | 福瑞股份 | 33.68% | 6.93% | 6.3分 |
| 5 | 天臣医疗 | 30.92% | 5.50% | 6.0分 |
| 6 | 之江生物 | 30.67% | 17.57% | 5.1分 |
| 8 | 康拓医疗 | 28.13% | 8.88% | 6.6分 |
| 10 | 浩欧博 | 27.70% | -16.76% | 4.8分 |
| 12 | 宝莱特 | 24.42% | -3.10% | 4.9分 |
| 14 | 易瑞生物 | 23.22% | 12.98% | 5.6分 |
| 16 | 南微医学 | 21.50% | 9.80% | 6.7分 |
| 18 | 大博医疗 | 19.93% | 14.27% | 6.9分 |
| 20 | 透景生命 | 19.03% | 8.26% | 5.5分 |
| 22 | 安杰思 | 17.79% | 11.01% | 6.4分 |
| 24 | 正川股份 | 17.46% | 0.25% | 4.2分 |
| 26 | 爱威科技 | 17.10% | 8.25% | 6.4分 |
| 28 | 仁度生物 | 16.62% | 6.05% | 5.7分 |
| 30 | 凯普生物 | 16.45% | 2.77% | 5.3分 |
| 32 | 港通医疗 | 15.64% | -0.88% | 5.1分 |
| 34 | 麦澜德 | 15.19% | -0.81% | 5.4分 |
| 36 | 天益医疗 | 14.97% | 5.48% | 5.8分 |
| 38 | 科华生物 | 14.48% | 2.63% | 5.0分 |
| 40 | 赛诺医疗 | 13.80% | 11.60% | 6.4分 |
| 42 | 维力医疗 | 13.73% | 6.34% | 6.6分 |
| 44 | 康德莱 | 13.55% | 2.39% | 6.2分 |
| 46 | 理邦仪器 | 13.42% | 4.39% | 6.0分 |
| 48 | 楚天科技 | 13.16% | 0.00% | 4.9分 |
| 50 | 安旭生物 | 12.46% | 5.84% | 5.9分 |
| 52 | 美康生物 | 12.05% | 2.76% | 5.5分 |
| 54 | 艾德生物 | 11.91% | 2.50% | 6.2分 |
| 56 | 利德曼 | 11.42% | 3.35% | 5.9分 |
| 58 | 国发股份 | 11.01% | 6.82% | 5.8分 |
| 60 | 科美诊断 | 10.90% | 3.34% | 6.0分 |
| 62 | 达安基因 | 10.59% | -0.16% | 5.5分 |
| 64 | 正海生物 | 10.09% | 2.34% | 5.7分 |
| 66 | 九安医疗 | 9.80% | 7.04% | 6.0分 |
| 68 | 拱东医疗 | 9.42% | 2.11% | 6.1分 |
| 70 | 欧普康视 | 8.87% | 1.85% | 5.7分 |
| 72 | 济高发展 | 8.59% | -4.82% | 4.1分 |
| 74 | 健帆生物 | 8.26% | 0.97% | 5.4分 |
| 76 | 奥美医疗 | 8.00% | 2.15% | 5.9分 |
| 78 | 爱朋医疗 | 7.62% | -0.49% | 3.9分 |
| 80 | 西山科技 | 7.37% | 2.36% | 5.2分 |
| 82 | 万孚生物 | 7.03% | 1.61% | 5.2分 |
| 84 | 新华医疗 | 6.83% | 2.56% | 6.2分 |
| 86 | 奥泰生物 | 6.39% | 2.02% | 6.2分 |
| 88 | 海尔生物 | 6.09% | 0.64% | 6.1分 |
| 90 | 惠泰医疗 | 5.65% | -1.70% | 5.0分 |
| 92 | 威高血净 | 5.06% | -0.19% | 5.8分 |
| 94 | 华大智造 | 4.30% | 3.41% | 4.6分 |
| 96 | 万东医疗 | 4.17% | 1.72% | 5.7分 |
| 98 | 安图生物 | 3.71% | 1.16% | 6.0分 |
| 100 | 山东药玻 | 1.62% | 1.39% | 6.0分 |
| 102 | 济民健康 | 0.00% | 3.55% | 5.0分 |
| 104 | 海泰新光 | -0.57% | 0.45% | 5.6分 |
| 106 | 开立医疗 | -2.34% | 1.21% | 5.1分 |
| 108 | 新产业 | -6.05% | -1.18% | 5.2分 |
| 110 | - | -10.78% | 12.61% | 分 |
| 112 | 博拓生物 | - | -2.39% | 4.2分 |
| 114 | 山外山 | - | 0.49% | 6.2分 |
| 116 | 安必平 | - | 6.01% | 4.2分 |
| 118 | 昊海生科 | - | 2.47% | 5.2分 |
| 120 | 微电生理 | - | 3.07% | 6.1分 |
| 122 | 奕瑞科技 | - | -0.81% | 6.1分 |
| 124 | 联影医疗 | - | 1.91% | 5.2分 |
| 126 | 澳华内镜 | - | -2.82% | 5.8分 |
| 128 | 华强科技 | - | 2.05% | 3.7分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 6/250 ， 2/250。
[{"date":"2025-03-31","value":"4.81","vol":"1.15"},{"date":"2024-12-31","value":"14.37","vol":"0.53"},{"date":"2024-09-30","value":"12.94","vol":"4.75"},{"date":"2024-06-30","value":"8.30","vol":"3.53"},{"date":"2024-03-31","value":"3.69","vol":"1.63"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.81 | 14.37 | 12.94 | 8.30 | 3.69 |
| 行业(%) | 1.15 | 0.53 | 4.75 | 3.53 | 1.63 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"83.48","vol":"51.81"},{"date":"2024-12-31","value":"84.75","vol":"52.63"},{"date":"2024-09-30","value":"84.74","vol":"53.58"},{"date":"2024-06-30","value":"85.15","vol":"53.70"},{"date":"2024-03-31","value":"84.46","vol":"53.55"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
83.48 | 84.75 | 84.74 | 85.15 | 84.46 |
| 行业(%) | 51.81 | 52.63 | 53.58 | 53.70 | 53.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/250 ， 31/250。
[{"date":"2025-03-31","value":"16.63","vol":"-0.92"},{"date":"2024-12-31","value":"6.27","vol":"0.64"},{"date":"2024-09-30","value":"19.84","vol":"0.79"},{"date":"2024-06-30","value":"18.38","vol":"0.16"},{"date":"2024-03-31","value":"19.53","vol":"-1.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
16.63 | 6.27 | 19.84 | 18.38 | 19.53 |
| 行业(%) | -0.92 | 0.64 | 0.79 | 0.16 | -1.36 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"40.92","vol":"-4.25"},{"date":"2024-12-31","value":"-2.53","vol":"-24.11"},{"date":"2024-09-30","value":"30.82","vol":"-20.40"},{"date":"2024-06-30","value":"13.49","vol":"8.56"},{"date":"2024-03-31","value":"12.01","vol":"-16.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
40.92 | -2.53 | 30.82 | 13.49 | 12.01 |
| 行业(%) | -4.25 | -24.11 | -20.40 | 8.56 | -16.42 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/250 ， 5/250。
[{"date":"2025-03-31","value":"0.13","vol":"0.08"},{"date":"2024-12-31","value":"0.55","vol":"0.35"},{"date":"2024-09-30","value":"0.43","vol":"0.26"},{"date":"2024-06-30","value":"0.28","vol":"0.18"},{"date":"2024-03-31","value":"0.12","vol":"0.08"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.55 | 0.43 | 0.28 | 0.12 |
| 行业(次) | 0.08 | 0.35 | 0.26 | 0.18 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"1.30","vol":"0.55"},{"date":"2024-12-31","value":"5.36","vol":"2.33"},{"date":"2024-09-30","value":"3.92","vol":"1.67"},{"date":"2024-06-30","value":"2.61","vol":"1.13"},{"date":"2024-03-31","value":"1.20","vol":"0.54"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.30 | 5.36 | 3.92 | 2.61 | 1.20 |
| 行业(次) | 0.55 | 2.33 | 1.67 | 1.13 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"37.95","vol":"4.01"},{"date":"2024-12-31","value":"38.92","vol":"29.58"},{"date":"2024-09-30","value":"33.16","vol":"15.37"},{"date":"2024-06-30","value":"18.91","vol":"13.04"},{"date":"2024-03-31","value":"34.54","vol":"2.55"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 37.95 | 38.92 | 33.16 | 18.91 | 34.54 |
| 行业 | 4.01 | 29.58 | 15.37 | 13.04 | 2.55 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.68","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"0.60","vol":"2.31"},{"date":"2024-03-31","value":"","vol":"0.06"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.68 | - | 0.60 | - |
| 行业 | 0.00 | 2.19 | 0.01 | 2.31 | 0.06 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 98/250 ， 104/250。
[{"date":"2025-03-31","value":"8.63","vol":"5.89"},{"date":"2024-12-31","value":"9.18","vol":"5.34"},{"date":"2024-09-30","value":"8.06","vol":"5.97"},{"date":"2024-06-30","value":"7.98","vol":"5.95"},{"date":"2024-03-31","value":"11.32","vol":"6.44"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
8.63 | 9.18 | 8.06 | 7.98 | 11.32 |
| 行业 | 5.89 | 5.34 | 5.97 | 5.95 | 6.44 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"8.30","vol":"4.77"},{"date":"2024-12-31","value":"8.86","vol":"4.32"},{"date":"2024-09-30","value":"7.75","vol":"4.82"},{"date":"2024-06-30","value":"7.70","vol":"4.90"},{"date":"2024-03-31","value":"10.93","vol":"5.37"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
8.30 | 8.86 | 7.75 | 7.70 | 10.93 |
| 行业 | 4.77 | 4.32 | 4.82 | 4.90 | 5.37 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 91/250 ， 91/250。
[{"date":"2025-03-31","value":"11.31","vol":"21.24"},{"date":"2024-12-31","value":"10.73","vol":"21.92"},{"date":"2024-09-30","value":"11.16","vol":"21.09"},{"date":"2024-06-30","value":"11.29","vol":"21.07"},{"date":"2024-03-31","value":"10.27","vol":"20.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
11.31 | 10.73 | 11.16 | 11.29 | 10.27 |
| 行业(%) | 21.24 | 21.92 | 21.09 | 21.07 | 20.36 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.13","vol":"0.57"},{"date":"2024-12-31","value":"0.12","vol":"0.55"},{"date":"2024-09-30","value":"0.13","vol":"0.38"},{"date":"2024-06-30","value":"0.13","vol":"0.37"},{"date":"2024-03-31","value":"0.11","vol":"0.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.13 | 0.12 | 0.13 | 0.13 | 0.11 |
| 行业(%) | 0.57 | 0.55 | 0.38 | 0.37 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国信证券 | 2025-06-15 | 买入 | 买入 |
| 国泰海通证券 | 2025-05-26 | 买入 | |
| 国联民生 | 2025-05-14 | 买入 | |
| 光大证券 | 2025-04-28 | 买入 | |
| 中信证券 | 2025-04-25 | 增持 | |
| 东方证券 | 2025-04-24 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.40","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.64","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.61","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.55","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.17","blueLineValue":"0.80","type":"YC"}]